Navigation Links
Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
Date:1/23/2013

SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced a preliminary (unaudited) estimate of net product revenue from sales of OFIRMEV® (acetaminophen) injection for the three-months ended December 31, 2012, of approximately $17.1 million.

"We ended 2012 on a high note, with fourth quarter revenues exceeding the guidance given in our announcement of our third quarter 2012 financial results," said Ted Schroeder , President and CEO of Cadence. "We believe that our strategy to increase access to OFIRMEV within the hospital and to build awareness of the product's utility in multi-modal pain management has resulted in growing sales, and we look forward to continuing this momentum in 2013."

Revenue Guidance
As of January 23, 2013, Cadence expects that net product revenue from sales of OFIRMEV for the twelve months ending December 31, 2013, will range from approximately $94.0 million to $100.0 million.

A more complete discussion of Cadence's financial results for the year ended December 31, 2012, will occur during the Company's regularly scheduled quarterly conference call.

About OFIRMEV® (Acetaminophen) Injection
OFIRMEV (acetaminophen) injection (1000 mg / 100 mL, 10 mg / mL; for intravenous use only), Cadence Pharmaceuticals' proprietary intravenous formulation of acetaminophen, is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever. The FDA approval of OFIRMEV was based on data from clinical trials in approximately 1,020 adult and 355 pediatric
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
2. Cadence Pharmaceuticals to Host Analyst and Investor Day
3. Cadence to Open Finished Medical Device Facility
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City On November 28, 2012
5. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
6. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
7. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
8. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
10. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
11. Vanda Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on February 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014  As the Medical Affairs, role ... leaders in this area are exploring methods to develop ... Medical Affairs Consortium at Best Practices, LLC is designed ... insights about the key challenges they face. The consortium ... through three virtual roundtable discussions where leaders discuss key ...
(Date:8/22/2014)...  Dr. Mark Rasak , MD is recognized ... Award in the field of Medicine as a result ... Dr. Rasak has over 15 years of ... the business; overseeing the daily operations; interventional cardiology; complex ... addition, he is an honored Fellow of the American ...
(Date:8/22/2014)... --  Zacks Equity Research highlights Epizyme (Nasdaq: EPZM - ... (Nasdaq: PNRA - Free Report ) as the Bear of ... Therapeutics (Nasdaq: FOLD - Free Report ), Sanofi (NYSE: ... Free Report ). Here is a synopsis of all ... The biotech bull market is far from over ...
Breaking Medicine Technology:Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6
... Althea Technologies, Inc., a leading provider of development ... its inaugural Health and Wellness Fair today. The fair ... daily activities to promote physical and mental health amongst ... encouraged to participate in daily challenges and talks. Today,s ...
... 2011 Delcath Systems, Inc. (NASDAQ: DCTH ) ... Life Sciences Management Access Conference on Tuesday, August 16, 2011 ... Financial Officer, will provide an overview of the Company,s business ... this conference is by invitation only. Delcath will offer a ...
Cached Medicine Technology:Althea Technologies Hosts Health and Wellness Week 2Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011 2Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011 3
(Date:8/23/2014)... 23, 2014 Teen drug and alcohol ... no different in Wilmington, NC. Substance abuse can happen ... victim to drug and alcohol dependency in higher numbers ... to overcome substance abuse, but don’t know where to ... facility can be a challenge because most treatment options ...
(Date:8/22/2014)... The IT manager of Top10BestSEOHosting.com is a web professional ... has recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) is ... GoDaddy is a popular supplier of cheap web hosting, ... at affordable rates. It offers three Linux shared hosting ... on the length of the contract. The longest contract ...
(Date:8/22/2014)... 22, 2014 Today, Zane Benefits, the ... on Account-Based Health Plans. , According to Zane Benefits, ... strategy to lower the cost of healthcare without reducing ... spending accounts, however, can be confusing. , The new ... the four main types of ABHPs. It also explains ...
(Date:8/22/2014)... Recently, UWDress.com, a leading online supplier of wedding dresses and ... empire bridesmaid dresses to its product line. In ... for these high quality items. All of them are now ... off. , The company’s new items can definitely add ... its website. It is true that all its products are ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Japantown Dental ... a new teeth whitening technique. Air polishing is a ... appointments. , Dark teeth can be caused by a ... external stains and internal stains. External stains include coffee, ... be caused by certain medications, such as tetracycline, and ...
Breaking Medicine News(10 mins):Health News:Troubled Teens Wilmington Helpline Guides Adolescents to the Path of Recovery 2Health News:Discounted Empire Bridesmaid Dresses Online At UWDress.com 2Health News:Japantown Dental Introduces Air Polishing 2
... have come one step closer to understanding how the ... common drugs, including some antibiotics, antihistamines and anti-psychotics, can ... estimated around 40-50% of all drugs in development will ... in the heart and, as a result, can cause ...
... Maureen Salamon HealthDay Reporter , THURSDAY, Jan. 27 ... restaurant opening in his small Louisiana town, where vacant storefronts ... Burley, an assistant professor of sociology at Southeastern Louisiana University, ... of flat-screened TVs -- one in every booth -- along ...
... , THURSDAY, Jan. 27 (HealthDay News) -- U.S. health authorities ... patients using Truvada, the once-a-day combination pill that was shown ... high-risk individuals. The guidance, from experts at the U.S. ... and bisexual men at high risk for contracting the virus ...
... unprecedented crisis in our health care system," reported J. Fred ... at today,s annual State of the Nation,s Health Care briefing. ... We have more uninsured people than ever before. We ... Health care costs are increasing at rates that the countryand ...
... Researchers from McGill University,s Rosalind and Morris Goodman Cancer ... University Health Centre (RI MUHC), the DanaFarber Cancer Institute ... that can accurately predict which breast cancer patients are ... not from the burdens associated with unnecessary treatment. ...
... stimulants tend to choose instant gratification or a smaller but ... reward is greater. Reduced value of a future reward, ... treatment of addiction. A new study in the February 2011 ... present a strategy for increasing the value of future rewards ...
Cached Medicine News:Health News:Victor Chang scientists unlock the 'gates' on sudden cardiac death 2Health News:TV: A Sneaky Part of the Food Pyramid 2Health News:TV: A Sneaky Part of the Food Pyramid 3Health News:CDC Issues Guidance on Daily Pill to Prevent Infection With HIV 2Health News:CDC Issues Guidance on Daily Pill to Prevent Infection With HIV 3Health News:ACP says Congress must find 'common ground' to address 'crisis in our health care system' 2Health News:ACP says Congress must find 'common ground' to address 'crisis in our health care system' 3Health News:Memory training explored as strategy for addiction treatment 2Health News:Memory training explored as strategy for addiction treatment 3
... is a monoclonal antibody based ... confirmatory identification of Neisseria gonorrhoeae. ... isolated, viable or fresh cultures. ... two minute rotation, a positive ...
Rapid Test Kit...
... The InTray™ GC is a ... detection of both Neisseria gonorrhoeae and ... a long shelf life and is ... system. Simply inoculate, incubate and ...
OneStep Strip Style Gonorrhea Test is a rapid direct binding test for the visual detection of gonorrhea antigen, in the secretory specimen and urine from urogenital system, as an aid in the diagnosis...
Medicine Products: